A case report by Lin et al. describes a patient with a presumed papillary craniopharyngioma diagnosis in a patient that ultimately refused surgery and was subsequently treated empirically with combined BRAF and MEK inhibition, demonstrating complete response, but with only two month follow up at time of publication [17]. This evidence concerns the gene MAP2K7 and Papillary Craniopharyngioma.